Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment.

Condurache, Dorina-Gabriela; Raisi-Estabragh, Zahra; Ghosh, Arjun K; Mamas, Mamas A

Abstract

Patients with cancer are at increased risk of ischemic heart disease (IHD). The increased risk of IHD in these patients is due to the interaction of shared risk factors, cancer type and stage, and immuno/chemotherapy and radiotherapy regimens. Management of IHD in cancer patients is challenging, due to atypical presentation, increased thrombotic and bleeding risk, and worse outcomes compared to patients without cancer. In this review, we will discuss the trends, outcomes, epidemiology and challenges in the diagnosis and treatment of IHD among cancer patients. [Abstract copyright: Copyright © 2024 Elsevier Inc. All rights reserved.]

Citation

Condurache, D.-G., Raisi-Estabragh, Z., Ghosh, A. K., & Mamas, M. A. (in press). Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment. Cardiology Clinics, 43(1), 57-67. https://doi.org/10.1016/j.ccl.2024.08.001

• Journal Article Type: Article
• Acceptance Date: Sep 27, 2024
• Online Publication Date: Sep 27, 2024
• Deposit Date: Dec 13, 2024
• Journal: Cardiology clinics
• Print ISSN: 0733-8651
• Electronic ISSN: 1558-2264
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 43
• Issue: 1
• Pages: 57-67
• DOI: https://doi.org/10.1016/j.ccl.2024.08.001
• Keywords: Coronary artery disease, Population heart, Cancer population, Neoplasms - epidemiology - therapy, Myocardial Ischemia - epidemiology - diagnosis - therapy, Risk Factors, Global Health, Incidence, Cardio-oncology, Humans
• Public URL: https://keele-repository.worktribe.com/output/1012848